Literature DB >> 9692994

Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.

B P Schlegel1, K Ratnam, T M Penning.   

Abstract

Aldo-keto reductases (AKR) are monomeric oxidoreductases that retain a conserved catalytic tetrad (Tyr, Lys, Asp, and His) at their active sites in which the Tyr acts as a general acid-base catalyst. In rat liver 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD, AKR1C9), a well-characterized AKR, the catalytic tyrosine is Tyr 55. This enzyme displays a high catalytic efficiency for a common AKR substrate 9,10-phenanthrenequinone (9,10-PQ). Surprisingly, Y55F and Y55S mutants of 3alpha-HSD reduced 9,10-PQ with high kcat values. This is the first report whereby the invariant catalytic tyrosine of an AKR has been mutated with retention of kcat values similar to wild-type enzyme. The Y55F and Y55S mutants displayed narrow substrate specificity and reduced select aromatic quinones and alpha-dicarbonyls. kcat versus pH profiles for steroid oxidoreduction catalyzed by wild-type 3alpha-HSD exhibited a single ionizable group with a pK= 7.0-7.5, which has been assigned to Tyr 55. This group was not evident in the kcat versus pH profiles for 9, 10-PQ reduction catalyzed by either wild-type or the Tyr 55 mutant enzymes, indicating that the protonation state of Tyr 55 is unimportant for 9,10-PQ turnover. Instead, wild-type and the active-site mutants Y55F, Y55S, H117A, D50N, K84R, and K84M showed the presence of a new titratable group with a pKb = 8.3-9.9. Thus, the group being titrated is not part of the tetrad. All the mutants decreased kcat/Km considerably more than they decreased kcat. Thus, the K84R mutant demonstrated a 30-fold decrease in the pH-independent value of kcat but 2200-fold decrease in the pH-independent value of kcat/Km. This suggests that all the tetrad residues influence quinone binding and that Lys 84 plays a dominant role in maintaining proper substrate orientation. Using wild-type enzyme, the energy of activation (Ea) for 9,10-PQ reduction was approximately 11 kcal/mol less than steroid oxidoreduction. The Ea for 9,10-PQ reduction was unchanged in the Tyr 55 mutants, suggesting that the reaction proceeds through the same low-energy barrier in the wild-type enzyme and these mutants. The retention of quinone reductase activity in this AKR in the absence of Tyr 55 with kcat versus pH rate profiles and activation energies identical to wild-type enzyme suggests that quinone reduction occurs via a mechanism that differs from 3-ketosteroid reduction. In this mechanism, the electron donor (NADPH) and acceptor (o-quinone) are bound in close proximity, which permits hydride transfer without formal protonation of the acceptor carbonyl by Tyr 55. This represents a rare example where one enzyme can catalyze the same chemical reaction (carbonyl reduction) by either acid catalysis or by a propinquity effect and where these two mechanisms can be discriminated by site-directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692994     DOI: 10.1021/bi980475r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Nonprocessive [2 + 2]e- off-loading reductase domains from mycobacterial nonribosomal peptide synthetases.

Authors:  Arush Chhabra; Asfarul S Haque; Ravi Kant Pal; Aneesh Goyal; Rajkishore Rai; Seema Joshi; Santosh Panjikar; Santosh Pasha; Rajan Sankaranarayanan; Rajesh S Gokhale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  Quantum model of catalysis based on a mobile proton revealed by subatomic x-ray and neutron diffraction studies of h-aldose reductase.

Authors:  Matthew P Blakeley; Federico Ruiz; Raul Cachau; Isabelle Hazemann; Flora Meilleur; Andre Mitschler; Stephan Ginell; Pavel Afonine; Oscar N Ventura; Alexandra Cousido-Siah; Michael Haertlein; Andrzej Joachimiak; Dean Myles; Alberto Podjarny
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

3.  Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3.

Authors:  Sergio Porté; Eva Valencia; Evgenia A Yakovtseva; Emma Borràs; Naeem Shafqat; Judit E Debreczeny; Ashley C W Pike; Udo Oppermann; Jaume Farrés; Ignacio Fita; Xavier Parés
Journal:  J Biol Chem       Date:  2009-04-05       Impact factor: 5.157

Review 4.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

5.  In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).

Authors:  Aya Kikuchi; Takashi Furutani; Hidenori Azami; Kazushi Watanabe; Tatsuya Niimi; Yoshiteru Kamiyama; Sadao Kuromitsu; Edwina Baskin-Bey; Marten Heeringa; Taoufik Ouatas; Kentaro Enjo
Journal:  Invest New Drugs       Date:  2014-07-01       Impact factor: 3.850

6.  Kinetic and structural evidence of the alkenal/one reductase specificity of human ζ-crystallin.

Authors:  Sergio Porté; Agrin Moeini; Irene Reche; Naeem Shafqat; Udo Oppermann; Jaume Farrés; Xavier Parés
Journal:  Cell Mol Life Sci       Date:  2010-09-11       Impact factor: 9.261

7.  Structural basis for substrate specificity in human monomeric carbonyl reductases.

Authors:  Ewa S Pilka; Frank H Niesen; Wen Hwa Lee; Yasser El-Hawari; James E Dunford; Grazyna Kochan; Vladimir Wsol; Hans-Joerg Martin; Edmund Maser; Udo Oppermann
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

Review 8.  The aldo-keto reductases (AKRs): Overview.

Authors:  Trevor M Penning
Journal:  Chem Biol Interact       Date:  2014-10-07       Impact factor: 5.192

9.  Direct evidence for a covalent ene adduct intermediate in NAD(P)H-dependent enzymes.

Authors:  Raoul G Rosenthal; Marc-Olivier Ebert; Patrick Kiefer; Dominik M Peter; Julia A Vorholt; Tobias J Erb
Journal:  Nat Chem Biol       Date:  2013-11-17       Impact factor: 15.040

Review 10.  Aldo-keto reductase (AKR) superfamily: genomics and annotation.

Authors:  Rebekka D Mindnich; Trevor M Penning
Journal:  Hum Genomics       Date:  2009-07       Impact factor: 4.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.